SSGJ-707

CAT: 0804-HY-P991628-01Size: 1 mgDry Ice: YesHazardous: No
CAT#:0804-HY-P991628-01Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
SSGJ-707 is a bispecific, recombinant humanized IgG4 monoclonal antibody inhibitor targeting PD-1 and VEGF. SSGJ-707 can be used for cancers research, such as advanced non-small cell lung cancer (NSCLC) and recurrent endometrial cancer[1]
UNSPSC
12352005
Target
PD-1/PD-L1; VEGFR
Related Pathways
Immunology/Inflammation; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Purity
98.6
Smiles
[SSGJ-707]
Molecular Weight
(241.16 kDa)
References & Citations
[1]Wu L, et al. A phase II trial to evaluate the safety and efficacy of SSGJ-707, a bispecific antibody targeting PD-1 and VEGF, as a monotherapy in patients with advanced NSCLC[J]. 2025.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P991522SSGJ-613
HY-P991597SSGJ-608
HY-112081-01BAY-707
HY-114877CG-707
HY-P991093NGM-707
HY-111360-01SPL-707
HY-112081ABAY-707 (acetate)
HY-W927726CRBN ligand-707
HY-RI03884-01Mmu-miR-707 inhibitor
HY-R03884A-01Mmu-miR-707 agomir

Alternative Products

CatalogName
T9901A-1886-01SSGJ-707
T9901A-1702-01SSGJ-613
T9901A-1804-01SSGJ-608
257013-01UCM 707
MBS3603353-01BAY-707
5367/10SGC 707
6562/25BAY 707
MBS5774963CG-707
MBS5783392P-707
MBS131323SGC-707

Popular Products